Lotus Health continues share buyback for employee incentives

Lotus Health Group Company announced its latest progress on a share repurchase program, approved on October 30, 2024. As of August 31, 2025, the company had cumulatively repurchased 24,967,600 shares, representing 1.39% of its total share capital. The total amount spent on these repurchases stands at CNY 124,849,586.63, with transaction prices ranging from a low of CNY 4.29 per share to a high of CNY 6.05 per share.

The share repurchase program, which commenced between October 30, 2024, and October 29, 2025, has a projected spending range of CNY 110m to CNY 150m. The company's board stated that the repurchased shares are exclusively earmarked for employee stock ownership plans or equity incentive schemes. This initiative aligns with the company's commitment to enhancing employee engagement and long-term value.

Lotus Health Group emphasizes its adherence to relevant regulations, including the "Self-regulatory Guidelines for Listed Companies No. 7 - Share Repurchase" by the Shanghai Stock Exchange, and will continue to disclose progress as required. The company reiterates its intention to make timely repurchase decisions based on market conditions within the stipulated period, urging investors to remain aware of potential investment risks.